Quinine induced thrombocytopenia is –
**Core Concept**
Quinine-induced thrombocytopenia is a rare but serious side effect of quinine therapy, characterized by the formation of autoantibodies against platelets, leading to their destruction. This condition is a classic example of an immune-mediated adverse drug reaction.
**Why the Correct Answer is Right**
Quinine-induced thrombocytopenia occurs due to the formation of autoantibodies against platelet glycoproteins, specifically GPIIb/IIIa. These autoantibodies activate the complement system, leading to platelet destruction and thrombocytopenia. The pathogenesis involves a complex interplay between the quinine-induced platelet activation, platelet membrane alterations, and the subsequent formation of autoantibodies.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the underlying mechanism of quinine-induced thrombocytopenia. While platelet activation is involved, it is not the primary cause of thrombocytopenia.
**Option B:** This option is incorrect because it refers to a different condition altogether. Quinine-induced thrombocytopenia is not a result of bone marrow suppression or platelet sequestration.
**Option C:** This option is incorrect because it is a broad term that encompasses various causes of thrombocytopenia, including immune-mediated, bone marrow suppression, and platelet destruction.
**Clinical Pearl / High-Yield Fact**
A key clinical pearl to remember is that quinine-induced thrombocytopenia can occur weeks to months after the initiation of quinine therapy, making it a diagnosis of exclusion. A high index of suspicion and prompt recognition are crucial to prevent complications.
**Correct Answer: D. Drug-induced immune thrombocytopenia.**